Molecular Partners AG Sponsored ADR (MOLN)
(Delayed Data from NSDQ)
$3.48 USD
-0.46 (-11.68%)
Updated Aug 6, 2025 12:46 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Molecular Partners AG Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MOLN 3.48 -0.46(-11.68%)
Will MOLN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MOLN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MOLN
Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet
MOLN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MOLN
12 Health Care Stocks Moving In Friday's After-Market Session
UBS AM Acquires Significant Stake in Molecular Partners AG
12 Health Care Stocks Moving In Tuesday's After-Market Session
Molecular Partners’ Promising Oncology Developments and Strategic Focus Earn Buy Rating
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin ...